← Open Payments lookup

JACKLYN EYRE: Open Payments

NPI 1336487198 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,818 in 80 payments from 15 companies in 2025. Trend: 2023 $2,258 · 2024 $1,852 · 2025 $1,818

Food & beverage: $1,818
CompanyPaymentsAmount
Novo Nordisk Inc35$583
Amgen Inc.14$290
Lilly USA, LLC10$276
AstraZeneca Pharmaceuticals LP4$261
Corcept Therapeutics2$105
Bayer Healthcare Pharmaceuticals Inc.3$63
Boehringer Ingelheim Pharmaceuticals, Inc.2$46
GlaxoSmithKline, LLC.2$43
ABBVIE INC.2$30
Biogen, Inc.1$25

Products named: Ozempic, FARXIGA, EVENITY, ZEPBOUND, MOUNJARO, Wegovy, Korlym, JARDIANCE.

Industry payments across TX — which companies pay providers there.